Industry Experts

Saurabh Paliwal has more than 20 years of cross-disciplinary leadership, entrepreneurship and innovation experience in the biopharma and life sciences industry. Saurabh is currently a Senior Director of 'NGS and Molecular Assays' at Arsenal Biosciences, where he is enabling the development of novel CAR-T cell therapies for Solid Tumors, and implementing 'omics technologies to develop a cutting-edge AI/ML model for Immunology. Before this, Saurabh was a Senior Director of 'Sequencing Research and Genomics' at Bristol Myers Squibb (BMS), where he led the application of cutting-edge multi-omics and precision medicine approaches for drug discovery programs in Oncology, Immunology, Cardiovascular and Neuroscience TAs. He has previously led teams at Sana Biotechnology focused on analytical genomics assays for cell & gene therapy; and at Genapsys developing genomics applications for its novel NGS platform. Saurabh was the cofounder & CEO of Euveda Biosciences, which developed an innovative microfluidics technology for drug discovery and companion diagnostics. Saurabh obtained his undergraduate degree at IIT Madras, and his Ph.D. and postdoc at Johns Hopkins University.